Scleroderma News

Corbus Pharmaceuticals announced Resunab has been granted fast track status by the FDA to investigate the treatment of scleroderma, according to a company press release.

Patients with systemic sclerosis showed a decrease in skin fibrosis and improvement in serological markers following treatment with human stem cell transplantation, according to researchers from the JSC National Scientific Medical Research Center in Astana, Kazakhstan.

Iloprost outperformed alprostadil in treating secondary Raynaud’s phenomenon and may prevent digital ulcers from developing, according to study findings.

A population-based study has been conducted to determine the prevalence of rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis across Greece, according to a recently presented data.

Functional limitations and fatigue remained stable during the course of disease in patients with systemic sclerosis, according to recently published research.

Temporomandibular joint disorder was common among patients with systemic sclerosis and was found to be correlated with disease severity, according to results of a study.

Patients with gastrointestinal symptoms related to systemic sclerosis may benefit from treatment with IV immunoglobulin therapy, according to recently presented data.

The European League Against Rheumatism Annual European Congress of Rheumatology, held in Rome earlier this month, produced a large amount of data from researchers from around the globe. Here we present the most popular meeting coverage items on Healio.com/Rheumatology based on readership statistics.

New data suggested Enbriet met its safety targets in the treatment of interstitial lung disease arising from systemic sclerosis, according to researchers who presented at the European League Against Rheumatism Annual European Congress of Rheumatology.

According to data presented at the European League Against Rheumatism Annual European Congress of Rheumatology, temporary work disability may be reduced with early intervention for musculoskeletal diseases.